News
ASCLF
1.900
NaN%
--
Centessa is the top performing foreign healthcare stock YTD
Seeking Alpha · 6d ago
Sagimet down as Chinese partner posts late-stage trial data for acne therapy
Seeking Alpha · 01/29 13:17
Weekly Report: what happened at ASCLF last week (0908-0912)?
Weekly Report · 09/15/2025 11:21
Weekly Report: what happened at ASCLF last week (0901-0905)?
Weekly Report · 09/08/2025 11:24
Weekly Report: what happened at ASCLF last week (0825-0829)?
Weekly Report · 09/01/2025 11:18
Weekly Report: what happened at ASCLF last week (0818-0822)?
Weekly Report · 08/25/2025 11:30
Weekly Report: what happened at ASCLF last week (0811-0815)?
Weekly Report · 08/18/2025 11:22
Weekly Report: what happened at ASCLF last week (0804-0808)?
Weekly Report · 08/11/2025 11:30
Weekly Report: what happened at ASCLF last week (0728-0801)?
Weekly Report · 08/04/2025 11:32
Weekly Report: what happened at ASCLF last week (0721-0725)?
Weekly Report · 07/28/2025 11:33
Weekly Report: what happened at ASCLF last week (0714-0718)?
Weekly Report · 07/21/2025 11:22
Weekly Report: what happened at ASCLF last week (0707-0711)?
Weekly Report · 07/14/2025 11:33
Weekly Report: what happened at ASCLF last week (0630-0704)?
Weekly Report · 07/07/2025 11:23
Weekly Report: what happened at ASCLF last week (0623-0627)?
Weekly Report · 06/30/2025 11:30
Weekly Report: what happened at ASCLF last week (0616-0620)?
Weekly Report · 06/23/2025 11:22
Weekly Report: what happened at ASCLF last week (0609-0613)?
Weekly Report · 06/16/2025 11:29
Weekly Report: what happened at ASCLF last week (0602-0606)?
Weekly Report · 06/09/2025 11:31
Weekly Report: what happened at ASCLF last week (0526-0530)?
Weekly Report · 06/02/2025 11:40
Weekly Report: what happened at ASCLF last week (0519-0523)?
Weekly Report · 05/26/2025 11:39
Weekly Report: what happened at ASCLF last week (0512-0516)?
Weekly Report · 05/19/2025 11:29
More
Webull provides a variety of real-time ASCLF stock news. You can receive the latest news about Ascletis Pharma through multiple platforms. This information may help you make smarter investment decisions.
About ASCLF
Ascletis Pharma Inc is an investment holding company mainly engaged in the research and development, production, and sales of pharmaceutical products. The Company focuses on viral diseases, non-alcoholic steatohepatitis (NASH) or primary biliary cholangitis (PBC), and oncology. The Company's product pipeline includes ASC22 for chronic hepatitis B functional cure, ASC10 for respiratory syncytial virus (RSV), ASC22 for human immunodeficiency virus (HIV) functional cure, ASC10 and ASC11 for COVID-19, ASC41 for NASH, ASC42 for PBC, ASC61 for solid tumors, ASC40 for moderate and severe acne, and others. The Company conducts its business in the domestic and overseas markets.